Clinical Trials Browser

INDUSTRY × Interventional × envafolimab × Clear all

NCT03667170 2026-03-25

KN035 for dMMR/MSI-H Advanced Solid Tumors

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04891198 2026-03-25

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04910386 2026-03-25

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT05024214 2026-03-25

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Phase 1/2 Recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular

NCT05112991 2026-03-25

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms

NCT07260305 2025-12-03

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

Phase 1 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03478488 2025-05-29

KN035-BTC

Phase 3 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT06074497 2025-02-07

This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.

Phase 1 Active not recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05068427 2024-08-07

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT04480502 2024-05-17

ENVASARC

Phase 2 Active not recruiting

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma

NCT03101488 2022-03-03

Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT03248843 2022-02-08

A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT02827968 2021-06-02

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors